Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition.

BACKGROUND: It is well established that parity and use of oral contraceptives reduce the risk of ovarian cancer, but the associations with other reproductive variables are less clear. METHODS: We examined the associations of oral contraceptive use and reproductive factors with ovarian cancer risk in...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Tsilidis, K, Allen, N, Key, T, Dossus, L, Lukanova, A, Bakken, K, Lund, E, Fournier, A, Overvad, K, Hansen, L, Tjønneland, A, Fedirko, V, Rinaldi, S, Romieu, I, Clavel-Chapelon, F, Engel, P, Kaaks, R, Schütze, M, Steffen, A, Bamia, C, Trichopoulou, A, Zylis, D, Masala, G, Pala, V, Galasso, R
Formatua: Journal article
Hizkuntza:English
Argitaratua: 2011
_version_ 1826270232716509184
author Tsilidis, K
Allen, N
Key, T
Dossus, L
Lukanova, A
Bakken, K
Lund, E
Fournier, A
Overvad, K
Hansen, L
Tjønneland, A
Fedirko, V
Rinaldi, S
Romieu, I
Clavel-Chapelon, F
Engel, P
Kaaks, R
Schütze, M
Steffen, A
Bamia, C
Trichopoulou, A
Zylis, D
Masala, G
Pala, V
Galasso, R
author_facet Tsilidis, K
Allen, N
Key, T
Dossus, L
Lukanova, A
Bakken, K
Lund, E
Fournier, A
Overvad, K
Hansen, L
Tjønneland, A
Fedirko, V
Rinaldi, S
Romieu, I
Clavel-Chapelon, F
Engel, P
Kaaks, R
Schütze, M
Steffen, A
Bamia, C
Trichopoulou, A
Zylis, D
Masala, G
Pala, V
Galasso, R
author_sort Tsilidis, K
collection OXFORD
description BACKGROUND: It is well established that parity and use of oral contraceptives reduce the risk of ovarian cancer, but the associations with other reproductive variables are less clear. METHODS: We examined the associations of oral contraceptive use and reproductive factors with ovarian cancer risk in the European Prospective Investigation into Cancer and Nutrition. Among 327,396 eligible women, 878 developed ovarian cancer over an average of 9 years. Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated using Cox proportional hazard models stratified by centre and age, and adjusted for smoking status, body mass index, unilateral ovariectomy, simple hysterectomy, menopausal hormone therapy, and mutually adjusted for age at menarche, age at menopause, number of full-term pregnancies and duration of oral contraceptive use. RESULTS: Women who used oral contraceptives for 10 or more years had a significant 45% (HR, 0.55; 95% CI, 0.41-0.75) lower risk compared with users of 1 year or less (P-trend, <0.01). Compared with nulliparous women, parous women had a 29% (HR, 0.71; 95% CI, 0.59-0.87) lower risk, with an 8% reduction in risk for each additional pregnancy. A high age at menopause was associated with a higher risk of ovarian cancer (>52 vs ≤ 45 years: HR, 1.46; 95% CI, 1.06-1.99; P-trend, 0.02). Age at menarche, age at first full-term pregnancy, incomplete pregnancies and breastfeeding were not associated with risk. CONCLUSION: This study shows a strong protective association of oral contraceptives and parity with ovarian cancer risk, a higher risk with a late age at menopause, and no association with other reproductive factors.
first_indexed 2024-03-06T21:37:38Z
format Journal article
id oxford-uuid:46d0ee68-a895-4d5a-8946-cd6296829a89
institution University of Oxford
language English
last_indexed 2024-03-06T21:37:38Z
publishDate 2011
record_format dspace
spelling oxford-uuid:46d0ee68-a895-4d5a-8946-cd6296829a892022-03-26T15:16:09ZOral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:46d0ee68-a895-4d5a-8946-cd6296829a89EnglishSymplectic Elements at Oxford2011Tsilidis, KAllen, NKey, TDossus, LLukanova, ABakken, KLund, EFournier, AOvervad, KHansen, LTjønneland, AFedirko, VRinaldi, SRomieu, IClavel-Chapelon, FEngel, PKaaks, RSchütze, MSteffen, ABamia, CTrichopoulou, AZylis, DMasala, GPala, VGalasso, RBACKGROUND: It is well established that parity and use of oral contraceptives reduce the risk of ovarian cancer, but the associations with other reproductive variables are less clear. METHODS: We examined the associations of oral contraceptive use and reproductive factors with ovarian cancer risk in the European Prospective Investigation into Cancer and Nutrition. Among 327,396 eligible women, 878 developed ovarian cancer over an average of 9 years. Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated using Cox proportional hazard models stratified by centre and age, and adjusted for smoking status, body mass index, unilateral ovariectomy, simple hysterectomy, menopausal hormone therapy, and mutually adjusted for age at menarche, age at menopause, number of full-term pregnancies and duration of oral contraceptive use. RESULTS: Women who used oral contraceptives for 10 or more years had a significant 45% (HR, 0.55; 95% CI, 0.41-0.75) lower risk compared with users of 1 year or less (P-trend, <0.01). Compared with nulliparous women, parous women had a 29% (HR, 0.71; 95% CI, 0.59-0.87) lower risk, with an 8% reduction in risk for each additional pregnancy. A high age at menopause was associated with a higher risk of ovarian cancer (>52 vs ≤ 45 years: HR, 1.46; 95% CI, 1.06-1.99; P-trend, 0.02). Age at menarche, age at first full-term pregnancy, incomplete pregnancies and breastfeeding were not associated with risk. CONCLUSION: This study shows a strong protective association of oral contraceptives and parity with ovarian cancer risk, a higher risk with a late age at menopause, and no association with other reproductive factors.
spellingShingle Tsilidis, K
Allen, N
Key, T
Dossus, L
Lukanova, A
Bakken, K
Lund, E
Fournier, A
Overvad, K
Hansen, L
Tjønneland, A
Fedirko, V
Rinaldi, S
Romieu, I
Clavel-Chapelon, F
Engel, P
Kaaks, R
Schütze, M
Steffen, A
Bamia, C
Trichopoulou, A
Zylis, D
Masala, G
Pala, V
Galasso, R
Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition.
title Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition.
title_full Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition.
title_fullStr Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition.
title_full_unstemmed Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition.
title_short Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition.
title_sort oral contraceptive use and reproductive factors and risk of ovarian cancer in the european prospective investigation into cancer and nutrition
work_keys_str_mv AT tsilidisk oralcontraceptiveuseandreproductivefactorsandriskofovariancancerintheeuropeanprospectiveinvestigationintocancerandnutrition
AT allenn oralcontraceptiveuseandreproductivefactorsandriskofovariancancerintheeuropeanprospectiveinvestigationintocancerandnutrition
AT keyt oralcontraceptiveuseandreproductivefactorsandriskofovariancancerintheeuropeanprospectiveinvestigationintocancerandnutrition
AT dossusl oralcontraceptiveuseandreproductivefactorsandriskofovariancancerintheeuropeanprospectiveinvestigationintocancerandnutrition
AT lukanovaa oralcontraceptiveuseandreproductivefactorsandriskofovariancancerintheeuropeanprospectiveinvestigationintocancerandnutrition
AT bakkenk oralcontraceptiveuseandreproductivefactorsandriskofovariancancerintheeuropeanprospectiveinvestigationintocancerandnutrition
AT lunde oralcontraceptiveuseandreproductivefactorsandriskofovariancancerintheeuropeanprospectiveinvestigationintocancerandnutrition
AT fourniera oralcontraceptiveuseandreproductivefactorsandriskofovariancancerintheeuropeanprospectiveinvestigationintocancerandnutrition
AT overvadk oralcontraceptiveuseandreproductivefactorsandriskofovariancancerintheeuropeanprospectiveinvestigationintocancerandnutrition
AT hansenl oralcontraceptiveuseandreproductivefactorsandriskofovariancancerintheeuropeanprospectiveinvestigationintocancerandnutrition
AT tjønnelanda oralcontraceptiveuseandreproductivefactorsandriskofovariancancerintheeuropeanprospectiveinvestigationintocancerandnutrition
AT fedirkov oralcontraceptiveuseandreproductivefactorsandriskofovariancancerintheeuropeanprospectiveinvestigationintocancerandnutrition
AT rinaldis oralcontraceptiveuseandreproductivefactorsandriskofovariancancerintheeuropeanprospectiveinvestigationintocancerandnutrition
AT romieui oralcontraceptiveuseandreproductivefactorsandriskofovariancancerintheeuropeanprospectiveinvestigationintocancerandnutrition
AT clavelchapelonf oralcontraceptiveuseandreproductivefactorsandriskofovariancancerintheeuropeanprospectiveinvestigationintocancerandnutrition
AT engelp oralcontraceptiveuseandreproductivefactorsandriskofovariancancerintheeuropeanprospectiveinvestigationintocancerandnutrition
AT kaaksr oralcontraceptiveuseandreproductivefactorsandriskofovariancancerintheeuropeanprospectiveinvestigationintocancerandnutrition
AT schutzem oralcontraceptiveuseandreproductivefactorsandriskofovariancancerintheeuropeanprospectiveinvestigationintocancerandnutrition
AT steffena oralcontraceptiveuseandreproductivefactorsandriskofovariancancerintheeuropeanprospectiveinvestigationintocancerandnutrition
AT bamiac oralcontraceptiveuseandreproductivefactorsandriskofovariancancerintheeuropeanprospectiveinvestigationintocancerandnutrition
AT trichopouloua oralcontraceptiveuseandreproductivefactorsandriskofovariancancerintheeuropeanprospectiveinvestigationintocancerandnutrition
AT zylisd oralcontraceptiveuseandreproductivefactorsandriskofovariancancerintheeuropeanprospectiveinvestigationintocancerandnutrition
AT masalag oralcontraceptiveuseandreproductivefactorsandriskofovariancancerintheeuropeanprospectiveinvestigationintocancerandnutrition
AT palav oralcontraceptiveuseandreproductivefactorsandriskofovariancancerintheeuropeanprospectiveinvestigationintocancerandnutrition
AT galassor oralcontraceptiveuseandreproductivefactorsandriskofovariancancerintheeuropeanprospectiveinvestigationintocancerandnutrition